Back to results
US 2021/0267938 A1Published application
Multicyclic compounds and methods of use thereof
AssigneesSunovion Pharmaceuticals Inc., PGI Drug Discovery LLC
InventorsLiming SHAO, John Emmerson CAMPBELL, Michael Charles HEWITT, Una CAMPBELL, Taleen G. HANANIA
Life of this patent
Estimating the term…
Abstract
Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.
Claims30
1-39. (canceled)
A compound of formula (Ma):
- or a pharmaceutically acceptable salt or stereoisomer thereof, wherein
- R1 and R2 are each independently (i) hydrogen, alkyl, alkoxyl, aminoalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, or aralkyl, each of which is optionally substituted;
- or (ii) —(CH2)p—R8, wherein R8 is SO2alkyl or SO2aryl, each of which is optionally substituted;
- or (iii) R1 and R2 together with the nitrogen atom to which they are attached form an optionally substituted heterocyclyl or heteroaryl;
- R3 and R4 are each independently (i) hydrogen, alkyl, alkoxyl, aminoalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, or aralkyl, each of which is optionally substituted;
- or (ii) —(CH2)p—R9, wherein R9 is CF3, CN, nitro, amino, hydroxyl, or cycloalkoxyl, each of which is optionally substituted;
- or (iii) R3 and R4 together with the carbon atom to which they are attached form an optionally substituted cycloalkyl or heterocyclyl;
- or (iv) R3 and R1 together with the atoms to which they are attached form an optionally substituted heterocyclyl, and R4 is (i) or (ii);
- or (v) R3 and R4 are combined together to form a double bond and together with R1 and/or R2 and the atoms to which they are attached form an optionally substituted heteroaryl;
- R5 is (i) hydrogen, alkyl, alkoxyl, aminoalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, or aralkyl, each of which is optionally substituted;
- or (ii) —(CH2)p—R10, wherein R10 is CF3, CN, nitro, amino, hydroxyl, or cycloalkoxyl, each of which is optionally substituted;
- or (iii) R5 and R1 together with the atoms to which they are attached form an optionally substituted heterocyclyl;
- R6 and R7 are each independently (i) hydrogen, halo, alkyl, alkoxyl, aminoalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, or aralkyl, each of which is optionally substituted;
- or (ii) —(CH2)p—R11, wherein R11 is CF3, CN, nitro, amino (—NH2), hydroxyl, cycloalkoxyl, heteroaryl, or heterocyclyl, each of which is optionally substituted;
- or (iii) R6 and R7 together with the atoms to which they are attached form an optionally substituted aryl, heteroaryl, cycloalkyl or heterocyclyl ring;
- m is 0, 1, or 2;
- n is 0, 1, or 2;
- and
- each occurrence of p is independently 0, 1, or 2.
16 more elements
A compound, wherein the compound is:
- or a pharmaceutically acceptable salt or stereoisomer thereof.
A method of preparing a compound of formula (IIIa):
- or a pharmaceutically acceptable salt or stereoisomer thereof, the method comprising:
- (a) treating a hydroxyalkyl thiophene of formula (i):
- with an amino-aldehyde acetal and an acid, to produce a compound of formula (IIIa), wherein:
- m is 0;
- n is 1;
- R1 and R2 are each independently hydrogen or C1-C4 alkyl;
- R3 and R4 are each independently hydrogen or C1-C4 alkyl;
- R5 is hydrogen;
- and
- R6 and R7 are each independently hydrogen, halo, or C1-C4 alkyl.
7 more elements
Dependencies are inferred from the claim text.